Diastat and Macrodactyly - a phase IV clinical study of FDA data

Summary:

We study 1,811 people who take Diastat or have Macrodactyly. No report of Macrodactyly is found in people who take Diastat.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Oct, 02, 2022

No report is found.


What is Diastat?

Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.

What is Macrodactyly?

Macrodactyly (toes or fingers are abnormally large due to the overgrowth of the underlying bone and soft tissue) is found to be associated with 21 drugs and 19 conditions by eHealthMe.

Do you take Diastat and have Macrodactyly?

Check whether Macrodactyly is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Macrodactyly and when was it recovered:

Expand to all the drugs that have ingredients of diazepam:

Alternative drugs to, pros and cons of Diastat:

Macrodactyly treatments and more:

COVID vaccines that are related to Macrodactyly:

All the drugs that are associated with Macrodactyly:

All the conditions that are associated with Macrodactyly:

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: